Understand the source comparison
Adamax Stacking: Protocol Comparison
CJC1295/Ipamorelin Ghrelin receptor → GH/IGF-1 Administer 4–6 hours apart; Adamax AM, GH secretagogue PM Complementary neuroplasticity through independent pathways Ideal stack. Zero receptor overlap, IGF-1 supports BDNF effects Cerebrolysin BDNF/TrkB upregulat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- CJC1295/Ipamorelin
- Ghrelin receptor → GH/IGF-1
- Administer 4–6 hours apart; Adamax AM, GH secretagogue PM
- Complementary neuroplasticity through independent pathways
- Ideal stack. Zero receptor overlap, IGF-1 supports BDNF effects
- Cerebrolysin
- BDNF/TrkB upregulation
- Do not stack simultaneously. Cycle in alternating weeks if both required
- High redundancy. Competitive TrkB binding reduces efficacy of both
- Avoid simultaneous use; choose one based on research objective
- Thymalin
- Thymic immune modulation
- Can administer same day; separate by 2–3 hours minimum
- Indirect support. Immune health benefits neuroinflammation control
- Safe stack with complementary but distinct mechanisms
- Dihexa
- HGF/c-Met pathway (some BDNF cross-talk at high dose)
- Administer 6+ hours apart; monitor for overstimulation
- Moderate overlap. Both enhance synaptic density through related pathways
- Viable with careful dose titration and separation timing
- Noopept (synthetic)
- NMDA modulation, AMPA potentiation
- Avoid simultaneous use. Excessive NMDA modulation risk
- High overlap in glutamatergic modulation
- Better as alternatives than stack partners
- Metabolic peptides (AMPK modulators)
- Cellular energy pathways
- Can administer same day without separation
- Complementary. Energy supply supports cognitive demand
- Safe and potentially synergistic for metabolic research models